Alcyone Lifesciences

Alcyone Lifesciences was founded in 2010 to address the unmet needs in treatment of chronic neuropathological conditions. For many neurologic conditions including brain tumor, hydrocephalus, epilepsy and neurodegenerative disease, the current treatment modalities are sub-optimal.  Alcyone is dedicated to developing biologically inspired and clinically relevant solutions to significantly enhance current treatment modes for patients suffering from these chronic conditions.